Original research article Oral contraceptive use and risk of diabetes among Chinese women

Oral contraceptive (OC) use has been associated with alterations in carbohydrate metabolism. We examined the effect of OC use on the risk of diabetes among Chinese women. A nested case-control study was conducted among 57,130 women screened for diabetes at enrollment for the Shanghai Women’s Health Study, a population-based cohort study of Chinese women aged 40 –70 years in Shanghai, China. Included in this study were 259 women newly diagnosed with diabetes and 2072 age-matched controls (8 controls per case), randomly selected from women who tested negative for urine glucose. Multivariate-adjusted odds ratios (OR) and 95% confidence intervals (CI) were used to measure the strength of the association between OC use and diabetes risk. Overall, OC use was not associated with the risk of diabetes. Stratified analysis by menopausal status revealed a dose–response relationship between the duration of OC use and the risk of diabetes among premenopausal women (p for trend 0.02), with a 3.2-fold elevated risk observed among those who used OC longer than 1 year. Risk of diabetes diminished with increasing time since last OC use (p 0.02). Use of intrauterine devices was associated with a reduced risk of diabetes in both pre- and postmenopausal women (OR 0.67, CI: 0.48 – 0.93). These findings suggest that recent use (within 5 years) and continued use (1 year) of OCs may increase the risk of diabetes among Chinese women. However, the attributable risk for diabetes among OC users in the general population, if confirmed by further studies, appears to be small. © 2004 Elsevier Inc. All rights reserved.

[1]  K. Maki,et al.  Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. , 2000, Archives of internal medicine.

[2]  T. Sellers,et al.  Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study , 2000, International journal of cancer.

[3]  C. Cockram.  The epidemiology of diabetes mellitus in the Asia-Pacific region. , 2000, Hong Kong medical journal = Xianggang yi xue za zhi.

[4]  J. Petrie,et al.  The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. , 1999, The Journal of clinical endocrinology and metabolism.

[5]  Shi Hl,et al.  Prevalence of diabetes mellitus and associated risk factors in an adult urban population in Shanghai. , 1998, Diabetes & metabolism.

[6]  T. Buchanan,et al.  Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. , 1998, JAMA.

[7]  X. Pan,et al.  Prevalence of Diabetes and Its Risk Factors in China, 1994 , 1997, Diabetes Care.

[8]  I. Godsland,et al.  Is there a menopausal metabolic syndrome? , 1997, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  J. Manson,et al.  A Prospective Study of Oral Contraceptives and NIDDM Among U.S. Women , 1997, Diabetes Care.

[10]  R. Hanson,et al.  Comparison of screening tests for non-insulin-dependent diabetes mellitus. , 1993, Archives of internal medicine.

[11]  I. Godsland,et al.  Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. , 1993, Metabolism: clinical and experimental.

[12]  J. Manson,et al.  Oral contraceptive use and the risk of Type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women , 1992, Diabetologia.

[13]  S. Ratnam,et al.  Lipid and biochemical changes after low-dose oral contraception. , 1992, Contraception.

[14]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[15]  I. Godsland,et al.  The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism , 1991 .

[16]  L. M. Li,et al.  A pharmacodynamic and pharmacokinetic study of the Chinese No. 1 pill. , 1990, Contraception.

[17]  N. van der Vange,et al.  Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism. , 1987, American journal of obstetrics and gynecology.

[18]  L. Kovács,et al.  A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task force on Oral Contraceptives. , 1985, Contraception.

[19]  I. Godsland,et al.  THE EFFECTS OF CYPROTERONE ACETATE AND ETHINYL OESTRADIOL ON CARBOHYDRATE METABOLISM , 1984, Clinical endocrinology.

[20]  R. Ray,et al.  Oral contraceptive use: prospective follow-up of women with suspected glucose intolerance. , 1984, Contraception.

[21]  Zhong Xl.  Diabetes mellitus survey in China. , 1982 .

[22]  S. Sondheimer.  METABOLIC EFFECTS OF THE BIRTH CONTROL PILL , 1981, Clinical obstetrics and gynecology.

[23]  Birk Sa,et al.  Effects of norethindrone on carbohydrate and lipid metabolism. , 1975 .

[24]  W. Spellacy,et al.  The effect of the progestogen ethynodiol diacetate on glucose, insulin, and growth hormone after six months treatment. , 1972, Acta endocrinologica.

[25]  P. Beck.  Progestin Enhancement of the Plasma Insulin Response to Glucose in Rhesus Monkeys , 1969, Diabetes.

[26]  I. Godsland,et al.  Insulin resistance, secretion, and metabolism in users of oral contraceptives. , 1992, The Journal of clinical endocrinology and metabolism.